These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21448079)

  • 21. Interstitial fluid apolipoprotein A-II: an association with the occurrence of myocardial infarction.
    Luc G; Majd Z; Poulain P; Elkhalil L; Fruchart JC
    Atherosclerosis; 1996 Nov; 127(1):131-7. PubMed ID: 9006813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study.
    Pikula A; Beiser AS; Wang J; Himali JJ; Kelly-Hayes M; Kase CS; Yang Q; Seshadri S; Wolf PA
    Neurology; 2015 Feb; 84(5):472-9. PubMed ID: 25568296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of incident myocardial infarction by gender: Interactions with serum lipids, blood pressure and smoking. The Tromsø Study 1979-2012.
    Albrektsen G; Heuch I; Løchen ML; Thelle DS; Wilsgaard T; Njølstad I; Bønaa KH
    Atherosclerosis; 2017 Jun; 261():52-59. PubMed ID: 28448842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.
    Lind L; Vessby B; Sundström J
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):406-10. PubMed ID: 16306426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels.
    Hense HW; Stender M; Bors W; Keil U
    Atherosclerosis; 1993 Oct; 103(1):21-8. PubMed ID: 8280182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
    Liu S; Schmitz C; Stampfer MJ; Sacks F; Hennekens CH; Lindpaintner K; Ridker PM
    Atherosclerosis; 2002 Apr; 161(2):469-74. PubMed ID: 11888533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction.
    Hamsten A; Walldius G; Dahlén G; Johansson B; De Faire U
    Atherosclerosis; 1986 Feb; 59(2):223-35. PubMed ID: 3083833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity: A Pooled Cohort Analysis.
    Singh K; Chandra A; Sperry T; Joshi PH; Khera A; Virani SS; Ballantyne CM; Otvos JD; Dullaart RPF; Gruppen EG; Connelly MA; Ayers CR; Rohatgi A
    Circulation; 2020 Aug; 142(7):657-669. PubMed ID: 32804568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
    Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011094. PubMed ID: 30488422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients.
    Johannesen CDL; Mortensen MB; Langsted A; Nordestgaard BG
    J Am Coll Cardiol; 2021 Mar; 77(11):1439-1450. PubMed ID: 33736827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical activity, mediating factors and risk of colon cancer: insights into adiposity and circulating biomarkers from the EPIC cohort.
    Aleksandrova K; Jenab M; Leitzmann M; Bueno-de-Mesquita B; Kaaks R; Trichopoulou A; Bamia C; Lagiou P; Rinaldi S; Freisling H; Carayol M; Pischon T; Drogan D; Weiderpass E; Jakszyn P; Overvad K; Dahm CC; Tjønneland A; Bouton-Ruault MC; Kühn T; Peppa E; Valanou E; La Vecchia C; Palli D; Panico S; Sacerdote C; Agnoli C; Tumino R; May A; van Vulpen J; Benjaminsen Borch K; Oluwafemi Oyeyemi S; Quirós JR; Bonet C; Sánchez MJ; Dorronsoro M; Navarro C; Barricarte A; van Guelpen B; Wennberg P; Key TJ; Khaw KT; Wareham N; Assi N; Ward HA; Aune D; Riboli E; Boeing H
    Int J Epidemiol; 2017 Dec; 46(6):1823-1835. PubMed ID: 29025032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
    Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
    Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study.
    Ma J; Hennekens CH; Ridker PM; Stampfer MJ
    J Am Coll Cardiol; 1999 Apr; 33(5):1347-52. PubMed ID: 10193737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise type and intensity in relation to coronary heart disease in men.
    Tanasescu M; Leitzmann MF; Rimm EB; Willett WC; Stampfer MJ; Hu FB
    JAMA; 2002 Oct 23-30; 288(16):1994-2000. PubMed ID: 12387651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sedentary time, metabolic abnormalities, and all-cause mortality after myocardial infarction: A mediation analysis.
    Wu Z; Huang Z; Wu Y; Huang S; Wang Y; Zhao H; Chen S; Wu S; Gao X
    Eur J Prev Cardiol; 2019 Jan; 26(1):96-104. PubMed ID: 30289271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory markers modify the risk of recurrent coronary events associated with apolipoprotein A-I in postinfarction patients.
    Wang M; Corsetti J; McNitt S; Rich DQ; Sparks CE; Moss AJ; Zareba W
    J Clin Lipidol; 2017; 11(1):215-223. PubMed ID: 28391888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HbA(1c) levels in cardiovascular diseased patients without diabetes in a developing country.
    Sharma TK; Parchwani H; Kaushik GG; Shankar V; Dahiya K; Ghalaut VS; Sharma N
    Clin Lab; 2011; 57(7-8):517-22. PubMed ID: 21888015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men.
    Wannamethee SG; Whincup PH; Shaper AG; Rumley A; Lennon L; Lowe GD
    J Thromb Haemost; 2009 Oct; 7(10):1605-11. PubMed ID: 19682232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM).
    Dunder K; Lind L; Zethelius B; Berglund L; Lithell H
    Am Heart J; 2004 Oct; 148(4):596-601. PubMed ID: 15459588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.